Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
155.30
-0.70 (-0.45%)
Apr 29, 2026, 3:10 PM AST
TADAWUL:4015 Balance Sheet
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 357.59 | 261.67 | 284.28 | 141.18 | 112.63 | Upgrade
|
| Short-Term Investments | 0.73 | 0.69 | 0.8 | 1.06 | 39.36 | Upgrade
|
| Trading Asset Securities | 0.54 | 0.64 | 5.16 | 5.12 | - | Upgrade
|
| Cash & Short-Term Investments | 358.86 | 263 | 290.24 | 147.36 | 151.99 | Upgrade
|
| Cash Growth | 36.45% | -9.38% | 96.96% | -3.05% | -40.65% | Upgrade
|
| Accounts Receivable | 586.3 | 443.52 | 332.13 | 352.36 | 366.9 | Upgrade
|
| Other Receivables | 34.66 | 29.77 | 22.68 | 28.59 | 20.58 | Upgrade
|
| Receivables | 620.96 | 473.29 | 360.62 | 389.27 | 404.93 | Upgrade
|
| Inventory | 248.21 | 270.88 | 233.92 | 131.86 | 135.17 | Upgrade
|
| Prepaid Expenses | 5.44 | 4.57 | 3.99 | 4.52 | 3.09 | Upgrade
|
| Other Current Assets | 7.54 | 16.95 | 17.93 | 15.08 | 4.48 | Upgrade
|
| Total Current Assets | 1,241 | 1,029 | 906.7 | 688.08 | 699.67 | Upgrade
|
| Property, Plant & Equipment | 718.48 | 673.93 | 698.3 | 705.05 | 713.87 | Upgrade
|
| Long-Term Investments | 68.81 | 57.49 | 36.11 | 0.25 | 3.97 | Upgrade
|
| Other Intangible Assets | 17.27 | 11.53 | 13.05 | 14.43 | 14.79 | Upgrade
|
| Total Assets | 2,046 | 1,772 | 1,654 | 1,408 | 1,432 | Upgrade
|
| Accounts Payable | 40.79 | 42.61 | 67.98 | 39.79 | 41.81 | Upgrade
|
| Accrued Expenses | 117.15 | 104.19 | 66.75 | 51.98 | 59.55 | Upgrade
|
| Current Portion of Leases | 3.24 | 0.26 | 0.25 | 0.24 | 0.25 | Upgrade
|
| Current Income Taxes Payable | 35.06 | 28.8 | 25.51 | 17.72 | 19.74 | Upgrade
|
| Current Unearned Revenue | 1.5 | 2.14 | 3.77 | - | - | Upgrade
|
| Other Current Liabilities | 26.81 | 23.76 | 15.72 | 17.27 | 17.01 | Upgrade
|
| Total Current Liabilities | 224.55 | 201.76 | 179.97 | 126.99 | 138.36 | Upgrade
|
| Long-Term Leases | 13.19 | 1.83 | 2.16 | 2.4 | 1.72 | Upgrade
|
| Pension & Post-Retirement Benefits | 91.05 | 77.43 | 67.71 | 62.16 | 60.58 | Upgrade
|
| Total Liabilities | 328.79 | 281.03 | 249.84 | 191.55 | 200.66 | Upgrade
|
| Common Stock | 700 | 700 | 700 | 700 | 100 | Upgrade
|
| Retained Earnings | 1,168 | 950.81 | 811.99 | 591.35 | 1,170 | Upgrade
|
| Comprehensive Income & Other | -151.04 | -160.21 | -107.66 | -75.08 | -37.88 | Upgrade
|
| Total Common Equity | 1,717 | 1,491 | 1,404 | 1,216 | 1,232 | Upgrade
|
| Shareholders' Equity | 1,717 | 1,491 | 1,404 | 1,216 | 1,232 | Upgrade
|
| Total Liabilities & Equity | 2,046 | 1,772 | 1,654 | 1,408 | 1,432 | Upgrade
|
| Total Debt | 16.43 | 2.09 | 2.4 | 2.64 | 1.97 | Upgrade
|
| Net Cash (Debt) | 342.42 | 260.91 | 287.84 | 144.72 | 150.03 | Upgrade
|
| Net Cash Growth | 31.24% | -9.36% | 98.89% | -3.53% | -5.55% | Upgrade
|
| Net Cash Per Share | 4.89 | 3.73 | 4.11 | 2.07 | 15.00 | Upgrade
|
| Filing Date Shares Outstanding | 70 | 70 | 70 | 70 | 10 | Upgrade
|
| Total Common Shares Outstanding | 70 | 70 | 70 | 70 | 10 | Upgrade
|
| Working Capital | 1,016 | 826.92 | 726.73 | 561.09 | 561.3 | Upgrade
|
| Book Value Per Share | 24.53 | 21.29 | 20.06 | 17.38 | 123.16 | Upgrade
|
| Tangible Book Value | 1,699 | 1,479 | 1,391 | 1,202 | 1,217 | Upgrade
|
| Tangible Book Value Per Share | 24.28 | 21.13 | 19.88 | 17.17 | 121.68 | Upgrade
|
| Land | 58.68 | 58.56 | 59.73 | 60.46 | 62.59 | Upgrade
|
| Buildings | 277.25 | 271.46 | 224.31 | 177.98 | 176.67 | Upgrade
|
| Machinery | 784.17 | 719.15 | 564.16 | 515.41 | 510.48 | Upgrade
|
| Construction In Progress | 45.53 | 59.53 | 252.89 | 329.94 | 325.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.